ContagionLive published the article “Lyme Disease Vaccine Shows Antibodies 6 Months after Completion” by Senior Editor, John Parkinson, on December 1, 2022. The article provides details of the most recent investigational outcomes for Pfizer and Valneva’s Lyme disease vaccine candidate, VLA15.
Search Results for: vaccines
An article titled “New Virus Discovered in Swiss Ticks” published in International Global Biodefense on December 7, 2022, provides information about Alongshan virus (ALSV), which was first discovered in China in 2017. For the first time, scientists at the University of Zurich have detected the novel virus in Swiss ticks.
When the Lyme Disease Association Inc. (LDA) was contacted by a student at Duke Law who wanted to organize a group of students in a Lyme disease pro bono project, I was very excited about the possibilities…Lyme is not just a disease but a political nightmare… this was an opportunity to have some of the brightest and most motivated of our youth tackle this epidemic….The findings from this group of law students can be disseminated and used to empower patients, families, physicians, politicians, and researchers to unravel the secrets surrounding Lyme and provide solutions for Lyme and other tick-borne diseases across the globe.
Hassan Hakimi, et al., published “Advances in understanding red blood cell modifications by Babesia,” in PLOS Pathogens on September 15, 2022, to further investigate how the parasite invades and multiplies within red blood cells (RBCs) of mammalian hosts.
An article in Martha Vineyard Times announced that phase 3 trials for the Valneva-Pfizer Lyme disease vaccine candidate, VLA15, will take place on the Vineyard. This trial phase will investigate the extent to which the vaccine provides protection.
According to a new study conducted by Swedish researchers at Lund University, the messenger RNA (mRNA) from Pfizer’s COVID-19 vaccine is able to enter human liver where it triggers the […]
The FDA has just announced that they plan to postpone their scheduled advisory committee meeting on Pfizer’s COVID-19 vaccine for children ages 6 months to 4 years. They do not […]